What's more, we have established our own INEXbrandand occupied a placein the sametrade. In this regard, we have gained generally admitand praise from same trade and the massesofconsumers.
Last year, Enzon Pharmaceuticals terminated its co-development agreement with Inex after the FDA issued a "non-approvable" letter for Marqibo, saying Phase III trials were necessary.